The Valley Desk

NCT00271765 · Interventional trial

A Study of INO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Attack Patients Undergoing Primary Percutaneous Coronary Intervention

Overall registry status Completed

Phase 2

Conditions Acute Myocardial Infarction

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov